Browse studies

Find your next paid study

27,375 recruiting studies available now

Sarcopenia Characterization Using Magnetic Resonance Fingerprinting and Phosphorous Magnetic Resonance Spectroscopic Imaging Evaluation (SUSIE)

The goal of the proposed research is to investigate Magnetic Resonance (MR) Fingerprinting and P-MRS (Phosphorus-31 MR Spectroscopy) imaging for characterizati…

Sarcopenia

Estimated

~$10 – $750

Actual pay is set by the research site.

The Cleveland ClinicNCT04869813

Observational

Self-Directed Upper Extremity Gaming in Inpatients With Stroke: A Feasibility Study

STRIVE uses a camera mounted on the in-room TV and a connected laptop to track arm and hand movements during gameplay via markerless motion capture. No control…

Stroke

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Milap SandhuNCT07806097

Phase 1

A Phase 1b/II Study of Intratumoral CD40 Agonist 2141-V11 in Combination With Anti PD-1 and 5-Fluorouracil Therapy in Patients With Advanced Gastroesophageal Adenocarcinoma

The purpose of this study is to find out whether adding the drug 2141-V11 to standard treatment (anti-PD-1 immunotherapy with or without 5-FU) is a safe treatm…

Esophageal CancerAdvanced Esophageal CancerGastric Cancer+5 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT07818018

National Ophthalmic Genotyping and Phenotyping Network, Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

Background: The eyeGENE (Registered Trademark) program is a research resource for inherited eye conditions which includes genotypic and phenotypic data, imagi…

Inherited Ophthalmic DiseasesHypopigmentation DisorderCorneal Dystrophy+4 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Eye Institute (NEI)NCT06491615

Phase 2

A Randomized Phase II Trial Comparing Daratumumab-Bortezomib-Dexamethasone Versus Cyclophosphamide-Bortezomib-Dexamethasone in Newly Diagnosed Multiple Myeloma With Light Chain Cast Nephropathy (LCCN)

This study is being done to answer the following question: Can the addition of daratumumab-hyaluronidase to the usual treatment of bortezomib and dexamethason…

Myeloma Multiple

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Eastern Cooperative Oncology GroupNCT07085728

Observational

MEDBRIDGE: AI-Driven Risk Stratification and Care Transition Intervention to Improve Diabetes Medication Management

This study tests whether a support program led by a nurse case manager and community health worker can help patients with type 2 diabetes manage their medicati…

Type 2 DiabetesMedication AdherenceCare Transition+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Alabama at BirminghamNCT07599852

Phase 2

An Extension Study to Monitor Long-Term Safety of LUM-201 Treatment in Children With Idiopathic Growth Hormone Deficiency

This is a multi-national trial. The trial aims to study the long-term safety of LUM-201 in subjects with Idiopathic Pediatric Growth Hormone Deficiency (iPGHD)…

Growth Hormone Deficiency

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Lumos PharmaNCT05796440

Observational

Characterization and Modulation of Functional Connectivity and Fear Extinction Abnormalities in Obsessive-Compulsive Disorder

Obsessive-compulsive disorder (OCD) is associated with substantial impairments in quality of life and is among the most disabling psychiatric disorders. Exposu…

Obsessive Compulsive Disorder (OCD)

Estimated

~$10 – $750

Actual pay is set by the research site.

Yale UniversityNCT06834217

Phase 4

A Pilot Study To Assess The Effect Of Antepartum Perineal Massage Using A Pelvic Wand On Labor Agency And Pelvic Health

There is limited research on the optimal strategy to reduce obstetric laceration, postpartum urinary retention, and postpartum pelvic pain. In systematic revie…

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Beth Israel Deaconess Medical CenterNCT06986824

Phase 1

A Pilot Safety and Feasibility Study of Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Treatment for relapsed/refractory multiple myeloma continues to evolve with the approval of highly effective anti-BCMA CAR T therapies in recent years. However…

Multiple Myeloma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Washington University School of MedicineNCT06623630

Phase 2

An Open Label, Multicenter Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

Only subjects that have completed TILS-021, a Phase 2a Randomized, Double-Blind, Placebo-Controlled, Multicenter Dose-Ranging Study of Nasal Foralumab in Non-A…

Non-Active Secondary Progressive Multiple Sclerosis

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Tiziana Life Sciences LTDNCT06890923

Phase 3

A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjögren's Syndrome (SS)

The primary objective of this study is to evaluate the long-term safety and tolerability of dazodalibep.

Sjögren's Syndrome

Estimated

~$50 – $2,250

Actual pay is set by the research site.

AmgenNCT06747949